Contact

BÜHLMANN has become the prime calprotectin company within a few years, offering the broadest calprotectin product range with the automatable BÜHLMANN fCAL^® ELISA and the quantitative Quantum Blue^® Calprotectin rapid tests and the new immuno-turbidimetric BÜHLMANN fCAL^® turbo assay. For automation on ELISA robots we will continuously offer new CE-marked protocols for our BÜHLMANN fCAL^® ELISA, combined with our easy, safe and clean stool sampling and extraction CALEX^® Cap device. With IBDoc^® calprotectin, the smartphone based home testing solution, BÜHLMANN is bringing calprotectin monitoring to patients. In 2016, BÜHLMANN has launched its newest innovation the Quantum Blue^® Infliximab rapid test allowing clinicians immediate determination of trough levels.

BÜHLMANN does not only stand for calprotectin, but also for a selection of unique, high-quality assays for clinical routine use such as the BÜHLMANN Flow CAST^® product group for Basophil Activation Testing, and the BÜHLMANN GanglioCombi™ MAG ELISA , the only screening ELISA for anti-Ganglioside and anti-MAG antibody testing in one single assay.

BÜHLMANN continues to renew and enlarge its product portfolio, with the aim to be a leader in selected fields of in vitro diagnostics and in combining innovation with its traditional core values.